Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

New Therapeutic Opportunities for the Treatment of Squamous Cell Carcinomas: A Focus on Novel Driver Kinases.

  • Authors : Bensen R; Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA.; Brognard J

  • Source: International journal of molecular sciences [Int J Mol Sci] 2021 Mar 11; Vol. 22 (6). Date of Electronic Publication: 2021 Mar 11.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

×
Academic Journal

Ethyl gallate as a novel ERK1/2 inhibitor suppresses patient-derived esophageal tumor growth.

  • Authors : Liu F; China-US (Henan) Hormel Cancer Institute, Henan, China.; Zu X

  • Source: Molecular carcinogenesis [Mol Carcinog] 2019 Apr; Vol. 58 (4), pp. 533-543. Date of Electronic Publication: 2018 Dec 21.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8811105 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Isoalantolactone Inhibits Esophageal Squamous Cell Carcinoma Growth Through Downregulation of MicroRNA-21 and Derepression of PDCD4.

  • Authors : Wen SW; Department of Thoracic Surgery, Fourth Hospital, Hebei Medical University, Shijiazhuang, 050011, China.; Zhang YF

  • Source: Digestive diseases and sciences [Dig Dis Sci] 2018 Sep; Vol. 63 (9), pp. 2285-2293. Date of Electronic Publication: 2018 May 21.Publisher: Springer Science + Business Media Country of Publication: United States NLM ID: 7902782 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

The role of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 in esophageal squamous cell carcinoma.

  • Authors : Bao J; Department of Radiotherapy & Oncology, The Second Affiliated Hospital of Soochow University, Suzhou.; Department of Radiotherapy & Oncology, Tong Liao City Hospital, Tong Liao, Inner Mongolia.

  • Source: Medicine [Medicine (Baltimore)] 2020 Apr; Vol. 99 (15), pp. e19626.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

miR‑378a‑3p exerts tumor suppressive function on the tumorigenesis of esophageal squamous cell carcinoma by targeting Rab10.

  • Authors : Ding N; Department of Radiotherapy, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, Jiangsu 210009, P.R. China.; Sun X

  • Source: International journal of molecular medicine [Int J Mol Med] 2018 Jul; Vol. 42 (1), pp. 381-391. Date of Electronic Publication: 2018 Apr 24.Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9810955 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Effects of diphyllin as a novel V-ATPase inhibitor on TE-1 and ECA-109 cells.

  • Authors : Chen H; Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, Jiangsu 221000, P.R. China.; Liu P

  • Source: Oncology reports [Oncol Rep] 2018 Mar; Vol. 39 (3), pp. 921-928. Date of Electronic Publication: 2018 Jan 04.Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9422756 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Role of ALDH1 in the prognosis of esophageal cancer and its relationship with tumor microenvironment.

  • Authors : Chen MF; Department of Radiation Oncology, Chang Gung Memorial Hospital at Chiayi, Putz, Taiwan.; College of Medicine, Chang Gung University, Taoyuan, Taiwan.

  • Source: Molecular carcinogenesis [Mol Carcinog] 2018 Jan; Vol. 57 (1), pp. 78-88. Date of Electronic Publication: 2017 Oct 09.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8811105 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

TDO2 Overexpression Is Associated with Cancer Stem Cells and Poor Prognosis in Esophageal Squamous Cell Carcinoma.

  • Authors : Pham QT; Department of Molecular Pathology, Hiroshima University Institute of Biomedical and Health Sciences, Hiroshima, Japan.; Department of Pathology, University of Medicine and Pharmacy, Ho Chi Minh City, Vietnam.

  • Source: Oncology [Oncology] 2018; Vol. 95 (5), pp. 297-308. Date of Electronic Publication: 2018 Aug 22.Publisher: Karger Country of Publication: Switzerland NLM ID: 0135054 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1423-0232

Record details

×
Academic Journal

Ubiquitin-specific protease 4 improves the prognosis of the patients in esophageal cancer.

  • Authors : Yao R; Departments of Oncology, Huaian First People's Hospital, Nanjing Medical University, Huaian 223300, Jiangsu, China.; Departments of Oncology, Huaian First People's Hospital, Nanjing Medical University, Huaian 223300, Jiangsu, China.

  • Source: Cancer biomarkers : section A of Disease markers [Cancer Biomark] 2017 Sep 07; Vol. 20 (3), pp. 317-323.Publisher: IOS Press Country of Publication: Netherlands NLM ID: 101256509 Publication Model: Print Cited Medium: Internet ISSN: 1875-8592

Record details

×
Academic Journal

ALC1 knockdown enhances cisplatin cytotoxicity of esophageal squamous cell carcinoma cells by inhibition of glycolysis through PI3K/Akt pathway.

  • Authors : Li F; Department of Medical Oncology, Nanyang First People's Hospital, Nanyang 473012, China.; Zhang Z

  • Source: Life sciences [Life Sci] 2019 Sep 01; Vol. 232, pp. 116679. Date of Electronic Publication: 2019 Jul 21.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0375521 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  355 results for ""Carcinoma, Squamous Cell enzymology""